Research output per year
Research output per year
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming
SWITCH Research Group, Sablerolles, R. S. G., Rietdijk, W. J. R., Goorhuis, A., Postma, D. F., Visser, L. G., Geers, D., Garcia Garrido, H. M., Koopmans, M. P. G., Dalm, V. A. S. H., Kootstra, N. A., Huckriede, A. L. W., Lafeber, M., van Baarle, D., GeurtsvanKessel, C. H., de Vries, R. D. & van der Kuy, P. H. M., 10-Mar-2022, In: The New England journal of medicine. 386, 10, p. 951-963 13 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Intradermal Administration of Influenza Vaccine with Trehalose and Pullulan-Based Dissolving Microneedle Arrays
Tian, Y., Lee, J., van der Maaden, K., Bhide, Y., de Vries-Idema, J. J., Akkerman, R., O'Mahony, C., Jiskoot, W., Frijlink, H. W., Huckriede, A. L. W., Hinrichs, W. L. J., Bouwstra, J. A. & Beukema, M., Apr-2022, In: Journal of Pharmaceutical Sciences. 11 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Downloads (Pure) -
3 nieuwe vaccins onderweg: Fase 3-resultaten zijn hoopgevend
Huckriede, A. L. W., Feb-2021, In: Nederlands Tijdschrift voor Geneeskunde. 165, 8, C4794.Research output: Contribution to journal › Article › Professional
Open Access -
Advances in the development of entry inhibitors for sialic-acid-targeting viruses
Heida, R., Bhide, Y. C., Gasbarri, M., Kocabiyik, Ö., Stellacci, F., Huckriede, A. L. W., Hinrichs, W. L. J. & Frijlink, H. W., Jan-2021, In: Drug Discovery Today. 26, 1, p. 122-137 16 p.Research output: Contribution to journal › Review article › Academic › peer-review
Open AccessFile5 Citations (Scopus)36 Downloads (Pure) -
AstraZeneca: Prima vaccin, nu de organisatie nog
Huckriede, A. L. W., Apr-2021, In: Nederlands Tijdschrift voor Geneeskunde. 165, 14, C4840.Research output: Contribution to journal › Article › Professional
Open Access
Activities
-
International Society for Vaccines (External organisation)
Anke Huckriede (Member)
2022 → 2023Activity: Membership › Professional
-
Presentation for the Turkish Student Organisation in NL on coronavirus vaccines
Anke Huckriede (Speaker)
11-Mar-2021Activity: Talk and presentation › Academic presentation › Academic
-
Information on coronavirus vaccines
Anke Huckriede (Speaker)
3-Mar-2021Activity: Talk and presentation › Professional or public presentation › Professional
-
Presentation Groningse Chemische Kring on coronavirus vaccines
Anke Huckriede (Speaker)
11-Nov-2021Activity: Talk and presentation › Professional or public presentation › Professional
-
Information on coronavirus vaccines for Link Nurses & Docs
Anke Huckriede (Speaker)
19-Apr-2021Activity: Talk and presentation › Professional or public presentation › Professional
Press / Media
-
Novavax trekt vaccintwijfelaar Gemma over de streep: 'Deze techniek bestaat al langer, dat geeft een veilig gevoel'
17/02/2022
1 Media contribution
Press/Media: Expert Comment › Popular
-
Kwart van de mensen haalt neus op voor booster: 'Erg teleurstellend'
25/01/2022
1 item of Media coverage
Press/Media: Expert Comment › Popular
-
Na Janssen-vaccinatie mRNA-vaccins meest effectief als booster
Debbie van Baarle, Anke Huckriede & Douwe Postma
20/01/2022
1 item of Media coverage
Press/Media: Research › Professional
-
Ruim 10 procent gevaccineerden neemt geen booster: 'Kan problemen opleveren'
05/01/2022
1 item of Media coverage
Press/Media: Expert Comment › Popular
-
Vaccinoloog: hopelijk houdt effect boosterprik lang aan
04/01/2022
1 item of Media coverage
Press/Media: Expert Comment › Popular
Prizes
-
International Society for Vaccines – Nomination as board member
Huckriede, Anke (Recipient), 2021
Prize: Election to learned society › Professional
-
Intravacc – Nomination as Advisory Board member
Huckriede, Anke (Recipient), 2021
Prize: Election to learned society › Professional